CoChat

A new advance in alternative splicing databases: from catalogue to detailed analysis of regulation of expression and function of human alternative splicing variants

Open access
de la Grange, Pierre, Dutertre, Martin, Correa, Margot, Auboeuf, Didier · 2007 · BMC Bioinformatics

The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.

Abstract

Background: Most human genes produce several transcripts with different exon contents by using alternative promoters, alternative polyadenylation sites and alternative splice sites. Much effort has been devoted to describing known gene transcripts through the development of numerous databases. Nevertheless, owing to the diversity of the transcriptome, there is a need for interactive databases that provide information about the potential function of each splicing variant, as well as its expression pattern. Description: After setting up a database in which human and mouse splicing variants were compiled, we developed tools (1) to predict the production of protein isoforms from these transcripts, taking account of the presence of open reading frames and mechanisms that could potentially eliminate transcripts and/or inhibit their translation, i.e. nonsense-mediated mRNA decay and microRNAs; (2) to support studies of the regulation of transcript expression at multiple levels, including transcription and splicing, particularly in terms of tissue specificity; and (3) to assist in experimental analysis of the expression of splicing variants. Importantly, analyses of all features from transcript metabolism to functional protein domains were integrated in a highly interactive, user-friendly web interface that allows the functional and regulatory features of gene transcripts to be assessed rapidly and accurately. Conclusion: In addition to identifying the transcripts produced by human and mouse genes, fast DB http://www.fast-db.com provides tools for analyzing the putative functions of these transcripts and the regulation of their expression. Therefore, fast DB has achieved an advance in alternative splicing databases by providing resources for the functional interpretation of splicing variants for the human and mouse genomes. Because gene expression studies are increasingly employed in clinical analyses, our web interface has been designed to be as user-friendly as possible and to be readily searchable and intelligible at a glance by the whole biomedical community.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/1471-2105-8-180

Cites

51 of 51 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 The fast DB search pages. (A) The fast DB basic search page. (1) Keyword search; (2) Blast search; (3) checkbox to align an input sequence with a graphical representation of the exon/intron gene structure; (4) multiple-queries search: the user can upload a file with a stable gene EnsEMBL ID at each line. (B) The fast DB advanced search page. (1) Minimal and maximal length selection in base pairs; (2) selection of minimal and maximal number of exons; (3) selection of minimal and maximal number of cDNAs; (4) chromosome selection; (5) chromosome strand selection; (6) alternative transcriptional and splicing event selection; (7) NMD pathway targeting prediction selection.
Figure 1 The fast DB search pages. (A) The fast DB basic search page. (1) Keyword search; (2) Blast search; (3) checkbox to align an input sequence with a graphical representation of the exon/intron gene structure; (4) multiple-queries search: the user can upload a file with a stable gene EnsEMBL ID at each line. (B) The fast DB advanced search page. (1) Minimal and maximal length selection in base pairs; (2) selection of minimal and maximal number of exons; (3) selection of minimal and maximal number of cDNAs; (4) chromosome selection; (5) chromosome strand selection; (6) alternative transcriptional and splicing event selection; (7) NMD pathway targeting prediction selection.CC BY · PubMed Central
Figure 2 The fast DB "transcripts view" page of theRANBP9 human gene. (1) Graphical representation of the exon/intron gene structure. (2) Graphical representation of exon content of each transcript aligned with graphical representation of the gene. (3) AS events are highlighted in red. (4) Known CDS from the CCDS database. (5) Predicted ORFs. (6) Methionine positions are represented by a green "M". (7) Link to a multi-alignment of all translated ORF sequences. (8) Predicted NMD. (9) Exon with at least one predicted microRNA/transcript interaction site.
Figure 2 The fast DB "transcripts view" page of theRANBP9 human gene. (1) Graphical representation of the exon/intron gene structure. (2) Graphical representation of exon content of each transcript aligned with graphical representation of the gene. (3) AS events are highlighted in red. (4) Known CDS from the CCDS database. (5) Predicted ORFs. (6) Methionine positions are represented by a green "M". (7) Link to a multi-alignment of all translated ORF sequences. (8) Predicted NMD. (9) Exon with at least one predicted microRNA/transcript interaction site.CC BY · PubMed Central
Figure 3 Functional protein domain analysis andmulti-alignment of the translated sequences of predicted ORFs. (A) Functional protein domain analysis of the [GenBank:AB055311] transcript. (1) Diagram of the [GenBank:AB055311] ORF aligned with the corresponding transcript and gene graphical representations. (2) Form for selecting ORF exons for analysis. (3) Translated sequences of the selected ORF exons. (4) Form for selecting external websites to predict functional protein domains. (B) Multi-alignment of translated sequences of predicted ORFs. (1) Amino acids encoded by nucleotides from two exons (the amino acid is within the exon that yields two of the three codon nucleotides). (2) Methionines are represented by a green bold "M". (3) Red bold asterisks correspond to stop codons. (4) CDS from CCDS is highlighted in green.
Figure 3 Functional protein domain analysis andmulti-alignment of the translated sequences of predicted ORFs. (A) Functional protein domain analysis of the [GenBank:AB055311] transcript. (1) Diagram of the [GenBank:AB055311] ORF aligned with the corresponding transcript and gene graphical representations. (2) Form for selecting ORF exons for analysis. (3) Translated sequences of the selected ORF exons. (4) Form for selecting external websites to predict functional protein domains. (B) Multi-alignment of translated sequences of predicted ORFs. (1) Amino acids encoded by nucleotides from two exons (the amino acid is within the exon that yields two of the three codon nucleotides). (2) Methionines are represented by a green bold "M". (3) Red bold asterisks correspond to stop codons. (4) CDS from CCDS is highlighted in green.CC BY · PubMed Central
Figure 4 MicroRNA interaction site prediction. (1) Name of microRNA. (2) Positions of alignment between microRNA and genomic sequences. (3) Length of alignment between microRNA and genomic sequences. (4) Link to alignment between microRNA and genomic sequences. (5) MicroRNA sequence aligned with genomic sequence. (6) Transcript sequences aligned with the genomic sequence located at the same alignment position.
Figure 4 MicroRNA interaction site prediction. (1) Name of microRNA. (2) Positions of alignment between microRNA and genomic sequences. (3) Length of alignment between microRNA and genomic sequences. (4) Link to alignment between microRNA and genomic sequences. (5) MicroRNA sequence aligned with genomic sequence. (6) Transcript sequences aligned with the genomic sequence located at the same alignment position.CC BY · PubMed Central
Figure 5 Tissue specificity analysis in fast DB. (A) Tissue distribution of the 87 transcripts (cDNAs + ESTs) of the human RANBP9 gene. (1) Link to the tissue distribution of all fast DB cDNAs and ESTs. (2) Color legend and abbreviations of tissues in which transcripts are expressed. (3) Histogram of the tissue distribution of the human RANBP9 gene transcripts. (4) List of alternative events available for tissue specificity analysis. (B) Tissue specificity analysis of the skipping of human RANBP9 gene exon 5. (1) Color legend and schematic representation of the different transcript groups constituted for the study of this event. (2) Splice site positions used to define the different groups of transcripts. (3) Histogram of transcript tissue distribution: the skipping of exon 5 (red) seems to occur specifically in muscular (and possibly nervous) tissue(s). (4) Table summarizing the tissue distribution values for the transcript.
Figure 5 Tissue specificity analysis in fast DB. (A) Tissue distribution of the 87 transcripts (cDNAs + ESTs) of the human RANBP9 gene. (1) Link to the tissue distribution of all fast DB cDNAs and ESTs. (2) Color legend and abbreviations of tissues in which transcripts are expressed. (3) Histogram of the tissue distribution of the human RANBP9 gene transcripts. (4) List of alternative events available for tissue specificity analysis. (B) Tissue specificity analysis of the skipping of human RANBP9 gene exon 5. (1) Color legend and schematic representation of the different transcript groups constituted for the study of this event. (2) Splice site positions used to define the different groups of transcripts. (3) Histogram of transcript tissue distribution: the skipping of exon 5 (red) seems to occur specifically in muscular (and possibly nervous) tissue(s). (4) Table summarizing the tissue distribution values for the transcript.CC BY · PubMed Central
Figure 6 Analysis of the first exon of the [GenBank:AB055311] transcript. (A) The fast DB page for the analysis of the first exon of the [GenBank:AB055311] transcript. (1) Graphical representation of the [GenBank:AB055311] transcript aligned with the exon/intron structure of the human RANBP9 gene. Exon 1 was selected for analysis and labeled in red. (2) Scoring of splice site strength for the first exon of the [GenBank:AB055311] transcript. (3) Length and sequence of the first exon of [GenBank:AB055311]. (4) Analyses available for the selected transcript exon: transcription, UTR or splicing analyses. (5) Website selection for analyzing the selected exon for 5'UTR sequences. (B) List of websites available for analysis.
Figure 6 Analysis of the first exon of the [GenBank:AB055311] transcript. (A) The fast DB page for the analysis of the first exon of the [GenBank:AB055311] transcript. (1) Graphical representation of the [GenBank:AB055311] transcript aligned with the exon/intron structure of the human RANBP9 gene. Exon 1 was selected for analysis and labeled in red. (2) Scoring of splice site strength for the first exon of the [GenBank:AB055311] transcript. (3) Length and sequence of the first exon of [GenBank:AB055311]. (4) Analyses available for the selected transcript exon: transcription, UTR or splicing analyses. (5) Website selection for analyzing the selected exon for 5'UTR sequences. (B) List of websites available for analysis.CC BY · PubMed Central
Figure 7 "In silico PCR" and "Probe alignment" tools infast DB. (A) The "in silico PCR" option in fast DB. (1) Multi-alignment of transcript sequences of the human RANPB9 gene, exon by exon. (2) Explicit skipping of exon 5 by the [GenBank:BC063849] transcript shown on multi-alignment. (3) Direct selection of primers on multi-alignment. (4) Form for inputting primer sequences. (5) General information regarding input primers: length, GC percentage, TM, location and sequence. (6) Link to test the user's primers with ASePCR. (7) Expected PCR product for each transcript with its length and the link to its sequence. (8) Sequence of one expected PCR product, clickable in order to display the restriction enzyme cut sites for this sequence. (B) The "probe alignment" option in fast DB. (1) Graphical representation of probe sequences aligned with the genomic exon/intron structure. (2) Table with alignment information for all aligned probe sequences; data regarding the selected probe are highlighted in red. (3) Alignment of the selected probe sequence with the genomic sequence.
Figure 7 "In silico PCR" and "Probe alignment" tools infast DB. (A) The "in silico PCR" option in fast DB. (1) Multi-alignment of transcript sequences of the human RANPB9 gene, exon by exon. (2) Explicit skipping of exon 5 by the [GenBank:BC063849] transcript shown on multi-alignment. (3) Direct selection of primers on multi-alignment. (4) Form for inputting primer sequences. (5) General information regarding input primers: length, GC percentage, TM, location and sequence. (6) Link to test the user's primers with ASePCR. (7) Expected PCR product for each transcript with its length and the link to its sequence. (8) Sequence of one expected PCR product, clickable in order to display the restriction enzyme cut sites for this sequence. (B) The "probe alignment" option in fast DB. (1) Graphical representation of probe sequences aligned with the genomic exon/intron structure. (2) Table with alignment information for all aligned probe sequences; data regarding the selected probe are highlighted in red. (3) Alignment of the selected probe sequence with the genomic sequence.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 51 references

Cited by

See all 79

Metadata

Authors
de la Grange, P., Dutertre, M., Correa, M., & Auboeuf, D.
Affiliations
Inserm (FR)
Corresponding author
Auboeuf, Didier
Venue
BMC Bioinformatics
Published
2007-06-04
Volume
8
Issue
1
Pages
180-180
ISSN
1471-2105 (ISSN-L)
OpenAlex
W2140397282
Cited by
78
References
51
Citations by year
2025: 1 · 2023: 5 · 2022: 3 · 2021: 6 · 2020: 1 · 2019: 6 · 2018: 2 · 2017: 2 · 2016: 8 · 2015: 2 · 2014: 1 · 2013: 7 · 2012: 7
FWCI
2.65
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • BMC Bioinformatics (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders
Institut National de la Santé et de la Recherche Médicale
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Research and Splicing
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Phylogenetic Studies
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer-related molecular mechanisms research
Keywords
alternative splicing, splice variants, transcriptome database, nonsense-mediated mRNA decay, microRNA, alternative promoters, alternative polyadenylation, tissue-specific gene expression, transcript regulation, web interface
MeSH terms
Animals, Chromosome Mapping, Database Management Systems, Gene Expression Regulation, Humans, Transcription Factors, Genetic Variation, Information Storage and Retrieval, Proteome, RNA Splice Sites, Databases, Genetic, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A new advance in alternative splicing databases: from catalogue to detailed analysis of regulation of expression and function of human alternative splicing variants. https://app.cochat.ai/papers/10.1186/1471-2105-8-180
The paper
de la Grange, P., Dutertre, M., Correa, M., & Auboeuf, D. (2007). A new advance in alternative splicing databases: from catalogue to detailed analysis of regulation of expression and function of human alternative splicing variants. BMC Bioinformatics. https://doi.org/10.1186/1471-2105-8-180

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.